<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02791178</url>
  </required_header>
  <id_info>
    <org_study_id>2015/3034</org_study_id>
    <nct_id>NCT02791178</nct_id>
  </id_info>
  <brief_title>Optical Coherence Tomography in STEMI</brief_title>
  <official_title>Plaque Evaluation by Optical Coherence Tomography and Its Association With Microvascular Obstruction in Reperfused STEMI Patients - The POMS Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart Centre Singapore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Heart Centre Singapore</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this research proposal is to use OCT to investigate those
      morphological culprit plaque characteristics associated with the risk of developing MVO in
      reperfused STEMI patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The specific research objectives include:

        1. To use OCT to determine the type of plaque (plaque rupture, plaque erosion or calcified
           nodule) most associated with the presence and severity of MVO (as measured by IMR and
           cardiac MRI).

        2. To use OCT to investigate the relationship between the extent of tissue protrusion and
           the amount of residual stent thrombus with the presence and severity of MVO (as measured
           by IMR and cardiac MRI).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>Two years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">35</enrollment>
  <condition>STEMI</condition>
  <arm_group>
    <arm_group_label>STEMI patients</arm_group_label>
    <description>The patients presenting with a STEMI and undergoing PPCI will be screened and approached to participate in this study.
All patients to do Optical Coherence Tomography (OCT), Index of Microcirculatory Resistance (IMR) and Cardiac MRI.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Optical coherence tomography (OCT)</intervention_name>
    <description>Special camera to study part of your heart that was affected</description>
    <arm_group_label>STEMI patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Index of microcirculatory resistance (IMR)</intervention_name>
    <description>Special wire to study part of your heart that was affected</description>
    <arm_group_label>STEMI patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiac MRI</intervention_name>
    <description>Special scanner if the heart to assess the damage of your heart</description>
    <arm_group_label>STEMI patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples will be collected from all participants.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The patients presenting with a STEMI and undergoing PPCI will be screened and approached to
        participate in this study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Confirmed STEMI as per the in-charge consultant based on presenting history, ECG and
             angiogram findings.

          2. &lt; 12 hours of onset of chest pain.

          3. Ability to provide informed consent

        Exclusion Criteria:

          1. Previous myocardial infarction or coronary artery bypass graft surgery

          2. Cardiac arrest or cardiogenic shock

          3. Inability to advance the OCT catheter or to obtain good image quality

          4. Ostial lesions

          5. Significant renal impairment

          6. Contraindications for cardiac MRI

          7. Contraindication for adenosine (for IMR measurement)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Derek Hausenloy</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Heart Centre Singapore</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mung Peng</last_name>
    <phone>6704</phone>
    <phone_ext>2267</phone_ext>
    <email>wong.mung.peng@nhcs.com.sg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Derek Hausenloy</last_name>
    <email>derek.hausenloy@nhcs.com.sg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Heart Centre Singapore</name>
      <address>
        <city>Singapore</city>
        <zip>169609</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mung Peng</last_name>
      <phone>6704</phone>
      <phone_ext>2267</phone_ext>
      <email>wong.mung.peng@nhcs.com.sg</email>
    </contact>
    <investigator>
      <last_name>Derek Hausenloy</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 31, 2016</study_first_submitted>
  <study_first_submitted_qc>May 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2016</study_first_posted>
  <last_update_submitted>May 31, 2016</last_update_submitted>
  <last_update_submitted_qc>May 31, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

